Create a scope for our NSCLC liquid biopsy companion diagnostic FDA PMA submission
Based on my analysis of the current companion diagnostic landscape, here is the scope

Build our Alzheimer’s Phase III antibody US launch plan under FDA accelerated approval
Based on your strategic positioning, here is a 30-month cross-functional launch program

Map scenarios if our aortic valve launch faces delays due to polymer frame supply issues
Given current polymer constraints, here are 3 scenarios that’d affect valve manufacturing

Compare the most advanced Lp(a) cardiovascular launch plan with its closest competitor
This is an evidence-based comparison of two lead programs in the emerging Lp(a) market

Enhance our NSCLC diagnostic launch plan with new FDA qualification biomarker guidance
I've identified 12 critical enhancement opportunities that will significantly improve your POS
